Regular Article
An Association between Idiopathic Parkinson's Disease and Polymorphisms of Phase II Detoxification Enzymes: Glutathione S-Transferase M1 and Quinone Oxidoreductase 1 and 2

https://doi.org/10.1006/bbrc.2001.5868Get rights and content

Abstract

Individual vulnerability to reactive intermediates and oxidative stress accompanying metabolism of endogenous toxic compounds in the brain may promote the development of PD. Phase II detoxification enzymes such as glutathione S-transferase M1 (GSTM1), NAD(P)H:quinone oxidoreductase 1 (NQO1) and dihydronicotinamide riboside (NRH):quinone oxidoreductase 2 (NQO2) are important as cellular defenses against catecholamine-derived quinones and the oxidative stress that arises as a consequence of their metabolism. We conducted a study of the potential association between idiopathic Parkinson's disease and polymorphisms of GSTM1, NQO1, and NQO2. DNA samples from 111 unrelated outpatients with idiopathic PD and 100 unrelated healthy volunteers were analyzed. GSTM1 deletion polymorphism exhibited no positive association with PD (P = 0.596, odds ratio: 1.135), although GSTM1 were grouped into three genotypes (deletion/deletion, deletion/nondeletion, and nondeletion/nondeletion). In addition, polymorphism of the NQO1 gene caused by a C to T substitution in exon 3 presented no association with PD (P = 0.194, odds ratio: 1.31). However, polymorphism in the form of an insertion/deletion (I/D) of 29 base pairs (bp) nucleotides in the promoter region of the NQO2 gene, which contains four repeats of the putative core sequence (GGGCGGG) of the Sp1-binding cis-element, did associate with PD. The frequency of the D allele was significantly higher in patients with PD than in controls (P < 0.0001, odds ratio: 3.463). Our data suggested that the deletion of 29-bp nucleotides in the promoter region of the NQO2 gene associates with the development of PD.

References (32)

  • A.K. Jaiswal

    Human NAD(P)H:quinone oxidoreductase 2: Gene structure and tissue specific expression

    J. Biol. Chem.

    (1994)
  • S. Baez et al.

    Superoxide dismutase and catalase enhance autooxidation during one-electron reduction of aminochrome by NADH-cytochrome P450 reductase

    Biochem. Mol. Med.

    (1995)
  • A. Ahmadi et al.

    GSTM1 and mEPHX polymorphisms in Parkinson's disease and age of onset

    Biochem. Biophys. Res. Commun.

    (2000)
  • K. Jellinger

    Overview of morphological changes in Parkinson's disease

    Adv. Neurol.

    (1986)
  • J.R. Vaughan et al.

    Genetics of Parkinsonism: A review

    Annu. Hum. Genet.

    (2001)
  • Cited by (116)

    • Oxidative stress and neurodegeneration: The possible contribution of quinone reductase 2

      2018, Free Radical Biology and Medicine
      Citation Excerpt :

      Furthermore, QR2 levels are increased in the hippocampus [17] and cortex [18] of patients with Alzheimer's disease (AD). Polymorphic forms of QR2 have also been associated with Parkinson's disease [19]. Janda et al. showed that paraquat (1,1′-dimethyl-4,4′-bipyridinium) intoxication, which leads to Parkinson disease-like symptoms in mice and is the simplest AD model, is due principally to the action of QR2 [20].

    View all citing articles on Scopus
    1

    To whom correspondence and reprint requests should be addressed at Institute of Community Medicine, University of Tsukuba, Tennodai 1,1,1, Tsukuba, Ibaraki 305-8575, Japan. Fax: 0081-298-53-3460. E-mail: [email protected].

    View full text